Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1994 Oct;78(10):791–794. doi: 10.1136/bjo.78.10.791

Low glutathione reductase and peroxidase activity in age-related macular degeneration.

S M Cohen 1, K L Olin 1, W J Feuer 1, L Hjelmeland 1, C L Keen 1, L S Morse 1
PMCID: PMC504938  PMID: 7803358

Abstract

Age-related macular degeneration (ARMD) may result from events initiated by reactive oxygen species. Blood samples from 18 patients with ARMD and 18 similarly aged controls were analysed for activities of important antioxidants. Blood glutathione reductase activity was lower in patients with ARMD compared with controls (p = 0.035). The activities of glutathione peroxidase (p = 0.18) and erythrocyte superoxide dismutase (p = 0.29) were similar between the two groups by a Student's two sample t test. Logistic regression was used to determine which enzyme activities were associated with ARMD after adjusting for possible confounding variables: smoking history, age, multivitamin use, and cardiovascular disease. Glutathione reductase activity (p = 0.05) and glutathione peroxidase activity (p = 0.065) were significantly associated with ARMD by this analysis. The relation of glutathione reductase and glutathione peroxidase activity to ARMD merits further study.

Full text

PDF
791

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agergaard N., Jensen P. T. Procedure for blood glutathione peroxidase determination in cattle and swine. Acta Vet Scand. 1982;23(4):515–527. doi: 10.1186/BF03546770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balin A. K., Allen R. G. Mechanisms of biologic aging. Dermatol Clin. 1986 Jul;4(3):347–358. [PubMed] [Google Scholar]
  3. Bates C. J. Human riboflavin requirements, and metabolic consequences of deficiency in man and animals. World Rev Nutr Diet. 1987;50:215–265. doi: 10.1159/000414174. [DOI] [PubMed] [Google Scholar]
  4. Ferris F. L., 3rd Senile macular degeneration: review of epidemiologic features. Am J Epidemiol. 1983 Aug;118(2):132–151. doi: 10.1093/oxfordjournals.aje.a113624. [DOI] [PubMed] [Google Scholar]
  5. Ghafour I. M., Allan D., Foulds W. S. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol. 1983 Apr;67(4):209–213. doi: 10.1136/bjo.67.4.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goldberg J., Flowerdew G., Smith E., Brody J. A., Tso M. O. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol. 1988 Oct;128(4):700–710. doi: 10.1093/oxfordjournals.aje.a115023. [DOI] [PubMed] [Google Scholar]
  7. Gottsch J. D., Pou S., Bynoe L. A., Rosen G. M. Hematogenous photosensitization. A mechanism for the development of age-related macular degeneration. Invest Ophthalmol Vis Sci. 1990 Sep;31(9):1674–1682. [PubMed] [Google Scholar]
  8. Grey R. H., Burns-Cox C. J., Hughes A. Blind and partial sight registration in Avon. Br J Ophthalmol. 1989 Feb;73(2):88–94. doi: 10.1136/bjo.73.2.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hyman L. G., Lilienfeld A. M., Ferris F. L., 3rd, Fine S. L. Senile macular degeneration: a case-control study. Am J Epidemiol. 1983 Aug;118(2):213–227. doi: 10.1093/oxfordjournals.aje.a113629. [DOI] [PubMed] [Google Scholar]
  10. Johnson M. L. Aging of the United States population. The dermatologic implications. Dermatol Clin. 1986 Jul;4(3):371–377. [PubMed] [Google Scholar]
  11. Lawrence R. A., Burk R. F. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun. 1976 Aug 23;71(4):952–958. doi: 10.1016/0006-291x(76)90747-6. [DOI] [PubMed] [Google Scholar]
  12. Leibovitz B. E., Siegel B. V. Aspects of free radical reactions in biological systems: aging. J Gerontol. 1980 Jan;35(1):45–56. doi: 10.1093/geronj/35.1.45. [DOI] [PubMed] [Google Scholar]
  13. Leske M. C., Chylack L. T., Jr, Wu S. Y. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol. 1991 Feb;109(2):244–251. doi: 10.1001/archopht.1991.01080020090051. [DOI] [PubMed] [Google Scholar]
  14. MACDONALD A. E. CAUSES OF BLINDNESS IN CANADA: AN ANALYSIS OF 24,605 CASES REGISTERED WITH THE CANADIAN NATIONAL INSTITUTE FOR THE BLIND. Can Med Assoc J. 1965 Feb 6;92:264–279. [PMC free article] [PubMed] [Google Scholar]
  15. Marklund S., Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974 Sep 16;47(3):469–474. doi: 10.1111/j.1432-1033.1974.tb03714.x. [DOI] [PubMed] [Google Scholar]
  16. Newsome D. A., Swartz M., Leone N. C., Elston R. C., Miller E. Oral zinc in macular degeneration. Arch Ophthalmol. 1988 Feb;106(2):192–198. doi: 10.1001/archopht.1988.01060130202026. [DOI] [PubMed] [Google Scholar]
  17. Rogers K. M., Augusteyn R. C. Glutathione reductase in normal and cataractous human lenses. Exp Eye Res. 1978 Dec;27(6):719–721. doi: 10.1016/0014-4835(78)90041-6. [DOI] [PubMed] [Google Scholar]
  18. Rosenberg T. Prevalence of blindness caused by senile macular degeneration in Greenland. Arctic Med Res. 1987 Oct;46(2):64–70. [PubMed] [Google Scholar]
  19. Silverstone B. Z., Landau L., Berson D., Sternbuch J. Zinc and copper metabolism in patients with senile macular degeneration. Ann Ophthalmol. 1985 Jul;17(7):419–422. [PubMed] [Google Scholar]
  20. Straatsma B. R., Lightfoot D. O., Barke R. M., Horwitz J. Lens capsule and epithelium in age-related cataract. Am J Ophthalmol. 1991 Sep 15;112(3):283–296. doi: 10.1016/s0002-9394(14)76729-7. [DOI] [PubMed] [Google Scholar]
  21. Taylor H. R. Ultraviolet radiation and the eye: an epidemiologic study. Trans Am Ophthalmol Soc. 1989;87:802–853. [PMC free article] [PubMed] [Google Scholar]
  22. Thompson J. R., Du L., Rosenthal A. R. Recent trends in the registration of blindness and partial sight in Leicestershire. Br J Ophthalmol. 1989 Feb;73(2):95–99. doi: 10.1136/bjo.73.2.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tsang N. C., Penfold P. L., Snitch P. J., Billson F. Serum levels of antioxidants and age-related macular degeneration. Doc Ophthalmol. 1992;81(4):387–400. doi: 10.1007/BF00169100. [DOI] [PubMed] [Google Scholar]
  24. Weiter J. J. Macular degeneration. Is there a nutritional component? Arch Ophthalmol. 1988 Feb;106(2):183–184. doi: 10.1001/archopht.1988.01060130193022. [DOI] [PubMed] [Google Scholar]
  25. West S. K., Rosenthal F. S., Bressler N. M., Bressler S. B., Munoz B., Fine S. L., Taylor H. R. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol. 1989 Jun;107(6):875–879. doi: 10.1001/archopht.1989.01070010897038. [DOI] [PubMed] [Google Scholar]
  26. Young R. W. Pathophysiology of age-related macular degeneration. Surv Ophthalmol. 1987 Mar-Apr;31(5):291–306. doi: 10.1016/0039-6257(87)90115-9. [DOI] [PubMed] [Google Scholar]
  27. Young R. W. Solar radiation and age-related macular degeneration. Surv Ophthalmol. 1988 Jan-Feb;32(4):252–269. doi: 10.1016/0039-6257(88)90174-9. [DOI] [PubMed] [Google Scholar]
  28. el-Hazmi M. A., Warsy A. S. Glutathione reductase in the south-western province of Saudi Arabia--genetic variation vs. acquired deficiency. Haematologia (Budap) 1989;22(1):37–42. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES